SYRE

Spyre Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Capital Market|US

Price

$47.58

Market Cap

$2.87B

Beta

2.94

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)+55.74%

Revenue CAGR 3Y+238.70%

P/E Ratio0.0

PEG Ratio—

FCF Yield-5.89%

Debt / Equity0.00

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for SYRE.